Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Endometrial Neoplasms 7 Lymphatic Metastasis 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 3 Breast Neoplasms 3 Thyroid Cancer, Papillary 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Postoperative Complications 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lymphedema 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Clinical Stage I Gastric Cancer AJCC v8 2 Carcinoma, Transitional Cell 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Urologic Neoplasms 1 Ureteral Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Recurrence 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 Platelet Glycoprotein IV Deficiency 1 Parotid Neoplasms 1

Interventions

Gemcitabine 113 Cisplatin 77 Oxaliplatin 46 pembrolizumab 35 Fluorouracil 33 Capecitabine 31 durvalumab 27 Leucovorin 27 lenvatinib 26 Magnetic Resonance Spectroscopy 15 Irinotecan 14 Drug Therapy 13 Biopsy 13 Nivolumab 12 Albumin-Bound Paclitaxel 12 tislelizumab 11 Specimen Handling 11 Radiofrequency Ablation 11 130-nm albumin-bound paclitaxel 11 pemigatinib 10 apatinib 10 Taxes 10 Radiotherapy 10 Floxuridine 10 Folfox protocol 9 Bevacizumab 9 S 1 (combination) 8 Platinum 8 Photochemotherapy 8 Liver Transplantation 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cholangiocarcinoma × Lymph Node Excision × Clear all

NCT03796819 2021-12-09

LND for ICC

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Completed

Gastrointestinal

Lymphatic Metastasis, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡